EPCLUSA is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype 1-6 infection with or without cirrhosis (compensated).
EPCLUSA is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype 1-6 infection with or without cirrhosis (compensated).
All fields required unless otherwise noted.
Please provide the following information:
Co-pay Savings Program Benefits
-
•
Subject to the Gilead Support Path® Co-pay Savings Program (“Savings Program") Terms and Conditions, this program provides
the following financial assistance for the out-of-pocket costs for eligible commercially insured patients
with a valid prescription:
-
•
Up to a maximum of 25% of the catalog price for three bottles in cost-sharing assistance,
valid for 6 months from the time of first redemption with no monthly limit for the following products:
- ⚬ EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg)
- ⚬ If Gilead determines that a patient’s insurer (or its agent) has implemented a program that adjusts patient cost-sharing obligations based on the availability of support under the Savings Program (sometimes called a “co-pay maximizer program”), unless prohibited by law, Gilead may reduce or discontinue the cost-sharing assistance available under the program after providing assistance in an amount not to exceed the lesser of the Affordable Care Act (ACA) maximum limit or current Savings Program limit.
- ⚬ If Gilead determines that a patient’s insurer (or its agent) has implemented a program that excludes the financial assistance provided under the Savings Program from counting towards the patient’s deductible or out-of-pocket cost limitations (sometimes called an “accumulator adjustment program”), unless prohibited by law, Gilead may reduce the cost-sharing assistance available under the program to a per claim maximum of $25. Please contact Support Path at 1-855-769-7284 to determine if additional cost-sharing assistance is available.
- • These program benefits are subject to change for any reason at any time without notice.
Gilead Support Path® Co-pay Savings Program Terms and Conditions:
- • The Gilead Support Path Co-pay Savings Program (“Savings Program”) provides financial assistance for the out-of-pocket costs to eligible commercially insured patients as described in the Savings Program Benefits above. Savings Program benefits are limited to financial assistance for patient cost-sharing for the applicable Gilead product only.
- • The Savings Program can be used only by eligible residents of the US, Puerto Rico, or US territories at participating eligible pharmacies in the US, Puerto Rico, or US territories. Product must be dispensed in the US, Puerto Rico, or US territories. Patients must be at least 18 years old to use the Savings Program themselves or to enroll in the Savings Program on behalf of a minor.
- • To use the Savings Program, the patient (or the authorized representative under federal or state law enrolling on behalf of the patient, as applicable) must personally complete the enrollment process for the Savings Program. Third-party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the Savings Program. Any decision to enroll in the Savings Program must be made voluntarily by the patient.
-
•
The Savings Program is not insurance and is not intended to substitute for insurance. Uninsured and cash-paying patients are not eligible to use the Savings Program. The Savings Program benefit is valid only for prescriptions that are reimbursed by commercial insurance and is not valid for prescriptions that are eligible to be reimbursed:
- in whole or in part by Medicare or a Medicare Part D plan, Medicaid, TRICARE, VA, DOD, Puerto Rico Government Health Insurance Plan, or any other state or federally funded healthcare benefit program (collectively, “Government Programs”); or
- by commercial plans or other health or pharmacy benefit programs that reimburse for the entire cost of prescription drugs or prohibit the program's use.
- • Patients who begin receiving prescription benefits from Government Programs at any time must notify Gilead of this fact by contacting Support Path at 1-855-769-7284 and will no longer be eligible to use the Savings Program.
- • The Savings Program is limited to one per person and is not transferable. No substitutions are permitted. This Savings Program is offered to, and intended for the sole benefit of, eligible patients and may not be utilized for the benefit of third parties, including, without limitation, third-party payers, pharmacy benefit managers, or the agents of either. If Gilead determines that a patient’s insurer has implemented a program that adjusts patient cost-sharing obligations based on the availability of support under the Savings Program (sometimes called a “co-pay maximizer program”), unless prohibited by law, Gilead may reduce or discontinue the cost-sharing assistance available under the Savings Program after providing assistance in an amount not to exceed the lesser of the Affordable Care Act (ACA) out-of-pocket maximum or current Savings Program limit. If Gilead determines that a patient’s insurer has implemented a program that excludes the financial assistance provided under the Savings Program from counting towards the patient’s deductible or out-of-pocket cost limitations (sometimes called an “accumulator adjustment program”), unless prohibited by law, Gilead may reduce the cost-sharing assistance available under the Savings Program to a per claim maximum of $25. Patients may contact Support Path at 1-855-769-7284 to determine if additional cost-sharing assistance is available.
- • The Savings Program is only available with a valid prescription. No other purchase is necessary to redeem this offer.
- • The Savings Program cannot be combined with any other coupon, free trial, discount, prescription savings card, or other offer (including, without limitation, any program offered by a third-party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations). Patients are not eligible to use the Savings Program for a product if they are currently receiving free drug assistance through Gilead Sciences, Inc. (“Gilead”)’s patient assistance program for that product.
- • The Savings Program will not reimburse any payments made by Flexible Spending Account (FSA), Health Savings Account (HSA), Health Reimbursement Account (HRA), or any other payor, discount/co-pay program, or other offer.
- • Void where prohibited by law, taxed, or restricted.
- • Patient, pharmacist, and prescriber agree not to seek reimbursement for all, or any part of the benefit received by the patient through the Savings Program. Both patient and pharmacist are each individually responsible for reporting receipt of the saving benefit to any insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the Savings Program, as may be required.
- • It is illegal to sell, purchase, trade, or counterfeit, or offer to sell, purchase, trade, or counterfeit the Savings Program.
- • Certain information pertaining to your use of the Savings Program will be shared with Gilead, the sponsor of the program, and its affiliates. The information disclosed will include the patient co-pay ID, pharmacy demographics, prescriber information, and details relating to the claim, such as co-pay amount, insurance details, and the therapy received. For more information, please see the Gilead Privacy Statement and Consumer Health Data Privacy Policy available at www.gilead.com.
- • Gilead Sciences reserves the right to terminate, rescind, revoke, or modify the Savings Program for any reason at any time without notice.
-
•
Up to a maximum of 25% of the catalog price for three bottles in cost-sharing assistance,
valid for 6 months from the time of first redemption with no monthly limit for the following products:
What is EPCLUSA?
EPCLUSA is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype 1-6 infection with or without cirrhosis (compensated).
Important Safety Information
What is the most important information I should know about EPCLUSA?
EPCLUSA can cause serious side effects, including:
- Hepatitis B virus reactivation: Before starting EPCLUSA treatment, your healthcare provider will do blood tests to check for hepatitis B infection. If you have ever had hepatitis B, the hepatitis B virus could become active again during and after treatment with EPCLUSA. This may cause serious liver problems including liver failure and death. If you are at risk, your healthcare provider will monitor you during and after taking EPCLUSA.
What should I tell my healthcare provider before taking EPCLUSA?
- Tell your healthcare provider about all of your medical conditions, including if you have ever had hepatitis B infection, liver problems other than hepatitis C infection, or a liver transplant; if you have kidney problems or are on dialysis; if you have HIV; or if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed. It is not known if EPCLUSA will harm your unborn baby or pass into your breast milk.
- Tell your healthcare provider and pharmacist about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. EPCLUSA and certain other medicines may affect each other, or may cause side effects.
What are the possible side effects of EPCLUSA?
Serious side effects may also include:
- Slow heart rate (bradycardia): EPCLUSA, when taken with amiodarone (Cordarone®, Nexterone®, Pacerone®), a medicine used to treat certain heart problems, may cause slow heart rate. In some cases slow heart rate has led to death or the need for a pacemaker when amiodarone is taken with medicines containing sofosbuvir. Get medical help right away if you take amiodarone with EPCLUSA and get any of the following symptoms: fainting or near-fainting, dizziness or lightheadedness, not feeling well, weakness, extreme tiredness, shortness of breath, chest pains, confusion, or memory problems.
- The most common side effects of EPCLUSA in adults include headache and tiredness.
These are not all the possible side effects of EPCLUSA. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Important Facts about EPCLUSA including Important Warnings.EPCLUSA is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype 1-6 infection with or without cirrhosis (compensated).
Important Safety Information
What is the most important information I should know about EPCLUSA?
EPCLUSA can cause serious side effects, including:
- Hepatitis B virus reactivation: Before starting EPCLUSA treatment, your healthcare provider will do blood tests to check for hepatitis B infection. If you have ever had hepatitis B, the hepatitis B virus could become active again during and after treatment with EPCLUSA. This may cause serious liver problems including liver failure and death. If you are at risk, your healthcare provider will monitor you during and after taking EPCLUSA.
What should I tell my healthcare provider before taking EPCLUSA?
- Tell your healthcare provider about all of your medical conditions, including if you have ever had hepatitis B infection, liver problems other than hepatitis C infection, or a liver transplant; if you have kidney problems or are on dialysis; if you have HIV; or if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed. It is not known if EPCLUSA will harm your unborn baby or pass into your breast milk.
- Tell your healthcare provider and pharmacist about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. EPCLUSA and certain other medicines may affect each other, or may cause side effects.
What are the possible side effects of EPCLUSA?
Serious side effects may also include:
- Slow heart rate (bradycardia): EPCLUSA, when taken with amiodarone (Cordarone®, Nexterone®, Pacerone®), a medicine used to treat certain heart problems, may cause slow heart rate. In some cases slow heart rate has led to death or the need for a pacemaker when amiodarone is taken with medicines containing sofosbuvir. Get medical help right away if you take amiodarone with EPCLUSA and get any of the following symptoms: fainting or near-fainting, dizziness or lightheadedness, not feeling well, weakness, extreme tiredness, shortness of breath, chest pains, confusion, or memory problems.
- The most common side effects of EPCLUSA in adults include headache and tiredness.
These are not all the possible side effects of EPCLUSA. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Important Facts about EPCLUSA including Important Warnings.
Important Safety Information
What is the most important information I should know about EPCLUSA?
EPCLUSA can cause serious side effects, including:
- Hepatitis B virus reactivation: Before starting EPCLUSA treatment, your healthcare provider will do blood tests to check for hepatitis B infection. If you have ever had hepatitis B, the hepatitis B virus could become active again during and after treatment with EPCLUSA. This may cause serious liver problems including liver failure and death. If you are at risk, your healthcare provider will monitor you during and after taking EPCLUSA.
What should I tell my healthcare provider before taking EPCLUSA?
- Tell your healthcare provider about all of your medical conditions, including if you have ever had hepatitis B infection, liver problems other than hepatitis C infection, or a liver transplant; if you have kidney problems or are on dialysis; if you have HIV; or if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed. It is not known if EPCLUSA will harm your unborn baby or pass into your breast milk.
- Tell your healthcare provider and pharmacist about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. EPCLUSA and certain other medicines may affect each other, or may cause side effects.
What are the possible side effects of EPCLUSA?
Serious side effects may also include:
- Slow heart rate (bradycardia): EPCLUSA, when taken with amiodarone (Cordarone®, Nexterone®, Pacerone®), a medicine used to treat certain heart problems, may cause slow heart rate. In some cases slow heart rate has led to death or the need for a pacemaker when amiodarone is taken with medicines containing sofosbuvir. Get medical help right away if you take amiodarone with EPCLUSA and get any of the following symptoms: fainting or near-fainting, dizziness or lightheadedness, not feeling well, weakness, extreme tiredness, shortness of breath, chest pains, confusion, or memory problems.
- The most common side effects of EPCLUSA in adults include headache and tiredness.
These are not all the possible side effects of EPCLUSA. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Important Facts about EPCLUSA including Important Warnings.